Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=101"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=101

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03036150-086da0b1",
        "title": "Dapagliflozin vs Placebo: Time to the First Occurrence of Either of the Components of the Composite: CV Death or Hospitalization for Heart Failure.",
        "summary": "100 of 2152 against 138 of 2152; risk difference -1.8 points, 95% interval -3.1 to -0.4; NCT03036150, A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease",
        "record": "/library/comparisons/NCT03036150-086da0b1",
        "nct_id": "NCT03036150",
        "kind": "outcome",
        "participants": 4304,
        "risk_difference": {
          "value": -0.017657992565055763,
          "lower": -0.03144539019680092,
          "upper": -0.003993554184226016
        },
        "group_1": "100 of 2,152",
        "group_2": "138 of 2,152",
        "difference": "-1.8 points",
        "interval": "-3.1 to -0.4",
        "trial_title": "A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease"
      },
      {
        "id": "NCT03036150-0bba0389",
        "title": "Dapagliflozin vs Placebo: Time to the First Occurrence of Any of the Components of the Composite: ≥50% Sustained Decline in eGFR or Reaching ESRD or Renal Death.",
        "summary": "142 of 2152 against 243 of 2152; risk difference -4.7 points, 95% interval -6.4 to -3.0; NCT03036150, A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease",
        "record": "/library/comparisons/NCT03036150-0bba0389",
        "nct_id": "NCT03036150",
        "kind": "outcome",
        "participants": 4304,
        "risk_difference": {
          "value": -0.046933085501858735,
          "lower": -0.06404026020897553,
          "upper": -0.0299550667090716
        },
        "group_1": "142 of 2,152",
        "group_2": "243 of 2,152",
        "difference": "-4.7 points",
        "interval": "-6.4 to -3.0",
        "trial_title": "A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=102",
  "request_id": "0eGgemP-ghi4zh5K"
}